Pages

Wednesday, December 11, 2013

FDA advisory panel deems metreleptin effective, safe for generalized lipodystrophy only | Endocrinology

FDA advisory panel deems metreleptin effective, safe for generalized lipodystrophy only | Endocrinology

No comments: